CA8
Carbonic anhydrase-related protein
Also known as: CAH8_HUMAN, CALS, CARP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35219
- Gene
- CA8
- Ensembl
- ENSG00000178538
- Chromosome
- 8
- Canonical length
- 290 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene was initially named CA-related protein because of sequence similarity to other known carbonic anhydrase genes. However, the gene product lacks carbonic anhydrase activity (i.e., the reversible hydration of carbon dioxide). The gene product continues to carry a carbonic anhydrase designation based on clear sequence identity to other members of the carbonic anhydrase gene family. The absence of CA8 gene transcription in the cerebellum of the lurcher mutant in mice with a neurologic defect suggests an important role for this acatalytic form. Mutations in this gene are associated with cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CMARQ3). Polymorphisms in this gene are associated with osteoporosis, and overexpression of this gene in osteosarcoma cells suggests an oncogenic role. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>P35219|CA8
1 MADLSFIEDT VAFPEKEEDE EEEEEGVEWG YEEGVEWGLV FPDANGEYQS PINLNSREAR
61 YDPSLLDVRL SPNYVVCRDC EVTNDGHTIQ VILKSKSVLS GGPLPQGHEF ELYEVRFHWG
121 RENQRGSEHT VNFKAFPMEL HLIHWNSTLF GSIDEAVGKP HGIAIIALFV QIGKEHVGLK
181 AVTEILQDIQ YKGKSKTIPC FNPNTLLPDP LLRDYWVYEG SLTIPPCSEG VTWILFRYPL
241 TISQLQIEEF RRLRTHVKGA ELVEGCDGIL GDNFRPTQPL SDRVIRAAFQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CA8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 38 nTPM
- cerebellum: 14 nTPM
- epididymis: 9.6 nTPM
- amygdala: 5.8 nTPM
- basal ganglia: 5.8 nTPM
- placenta: 5.8 nTPM
Single-cell type
- renal collecting duct intercalated cells: 840 nCPM
- sertoli cells: 501 nCPM
- corticotrophs: 432 nCPM
- epididymal clear cells: 280 nCPM
- pituitary stem cells: 239 nCPM
- endometrial secretory cells: 224 nCPM
Immune cell
- basophil: 76 nTPM
- plasmacytoid DC: 3.1 nTPM
- eosinophil: 0.5 nTPM
- memory B-cell: 0.2 nTPM
- NK-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- cerebellum: 36 nTPM
- basal ganglia: 9.3 nTPM
- hypothalamus: 8.4 nTPM
- amygdala: 8 nTPM
- cerebral cortex: 8 nTPM
- pons: 7.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CA8.
Disease | AllUniProt
Conditions CA8 is implicated in, by any mechanism.
- Spinocerebellar ataxia, autosomal recessive, 34 (SCAR34) MIM:613227
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 99 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.24
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CA8 as an antibody target. Whether an autoantibody or antibody against CA8 could matter depends on whether native CA8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CA8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CA8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...